Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Bristol Myers deepens AI investment with Anthropic deal
Bristol Myers deploys Anthropic's Claude AI to accelerate drug discovery
Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees
Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
WTW: Employers aiming to bulk up AI use for health and benefits
How medication intelligence scales trust in healthcare tech innovation
Artificial intelligence is transforming pharma, but success depends on more than powerful algorithms. Download this whitepaper to…
Unlocking AI’s potential in biotech requires more than advanced models. Download this white paper to explore why trusted,…
As HCP expectations evolve, pharma engagement must evolve with them. Download this white paper to explore how AI-powered digital…
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have…
Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, embedding agentic AI into drug…
Market research shouldn’t lag behind decisions. With AI, organizations can transform it into a sensing engine, continuously…
